Anthony Tanoto Tan - Infectious Diseases

Author Information

Anthony Tanoto Tan is a prominent researcher affiliated with the Emerging Infectious Diseases (EID) Program at Duke-NUS Graduate Medical School, Singapore. His work primarily focuses on immunological responses to viral infections, with a particular emphasis on SARS-CoV-2, the virus responsible for COVID-19. He is actively involved in studying T cell responses, which are crucial for understanding immune protection and vaccine efficacy against infectious diseases.

Research Contributions

Anthony Tanoto Tan has made significant contributions to the field of infectious diseases, particularly in understanding the immune response to SARS-CoV-2. His research includes the study of T cell immunity in response to COVID-19 infections and vaccinations. He has investigated the differential effects of vaccine doses on T cell immunity, the early induction of functional T cells, and the mutations of SARS-CoV-2 variants that escape immune detection. His work is integral to developing effective vaccines and therapeutic strategies for COVID-19 and other infectious diseases.

Aliases

Anthony Tanoto Tan is known by several aliases in the academic community, including A. Tan, A. T. Tan, Anthony Tan, Anthony T. Tan, and Anthony T Tan. These variations are commonly used in his publications and citations.

Publication and Citation Metrics

Metric	Value
Citation Count	6461
H-index	35
Paper Count	94

Publications:

Mutations of SARS-CoV-2 variants of concern escaping Spike-specific T cells

DOI: 10.1101/2022.01.20.477163

Year: 2022

Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients

DOI: 10.1016/j.celrep.2021.108728

Year: 2021

Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2 infection

DOI: 10.1101/2021.06.26.21259239

Year: 2021

Rapid measurement of SARS-CoV-2 spike T cells in whole blood from vaccinated and naturally infected individuals.

DOI: 10.1172/JCI152379

Year: 2021

Differential Effects of the Second SARS-CoV-2 mRNA Vaccine Dose on T Cell Immunity in Naïve and COVID-19 Recovered Individuals

DOI: 10.2139/SSRN.3844997

Year: 2021

Immunological alterations after immunotherapy with short lived HBV‐TCR T cells associates with long‐term treatment response in HBV‐HCC

DOI: 10.1002/hep4.1857

Year: 2021

Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naive and COVID-19 recovered individuals

DOI: 10.1016/j.celrep.2021.109570

Year: 2021

The T cell response to SARS-CoV-2: kinetic and quantitative aspects and the case for their protective role

DOI: 10.1093/oxfimm/iqab006

Year: 2021

Rapid determination of the wide dynamic range of SARS-CoV-2 Spike T cell responses in whole blood of vaccinated and naturally infected

DOI: 10.1101/2021.06.29.450293

Year: 2021

Early T cell and binding antibody responses are associated with COVID-19 RNA vaccine efficacy onset

DOI: 10.1016/j.medj.2021.04.003

Year: 2021

Why Is Global Cooperation Important?

What are the Symptoms of Herpes?

What is Real-Time PCR?

How Does Antibiotic Resistance Develop?

What Are the Components of the DTaP Vaccine?

How Should One Prepare for a Throat Swab?

What is Herpes?

What are Histone Deacetylase Inhibitors?

What Technologies are Used in Genomic and Proteomic Studies?

Can Infectious Diseases Be Prevented?

Partnered Content Networks

Relevant Topics